While risk-based quality management has gained increasing acceptance across the clinical research enterprise, quantitative evidence on its financial impact has been limited. A new analysis coauthored by experts from CluePoints and the Tufts Center for the Study of Drug Development addresses this gap.

Clinical research professionals operate in an environment of constant change. New regulations, evolving guidance, increasing enforcement activity, and emerging technologies continue to shape how research organizations manage compliance and protect research participants. Keeping up requires more than reviewing regulatory updates. It means learning from experienced compliance leaders, connecting with peers facing similar challenges, and gaining practical strategies that can be applied immediately. 

If one takes the view that the tenets of patient centricity in healthcare include supporting not only patients but also the people who stand closest to them, then supporting the clinical research coordinators (CRCs) who have the most patient-facing role in clinical trials should be a critical focus, according to the creator of an award-winning poster presented earlier this year at ACRP 2026 in Orlando.